CORIFY Care SL (Corify) is a medical start-up focused on cardiac arrhythmias. We are developing a novel technology to improve the treatment of atrial fibrillation, which affects more than 30M patients worldwide.

CORIFY goal is changing the way in which atrial fibrillation patients are treated. Corify offers the first medical device that non-invasively can see the electrical activity of the heart without the need of catheters or complex MRI/CT mappings.

The Atrial Fibrillation Problem

Only in Europe, 6 million people in Europe suffer from Atrial Fibrillation (AF), the most common cardiac arrhythmia. By 2050, 2% of the world population will be affected by this condition. The highly effective treatment is ablation. However, a precise diagnosis comes first. This is where the challenge lies. Only with a detailed diagnosis, ablation treatments can be really effective.

The Solution: Acorys®

Corify develops Acorys®: a Non-invasive Electrocardiographic Imaging device that resolves the main shortcomings of existing solutions to identify the optimal treatment in each patient with Atrial Fibrillation.